Listas de Observação Ideias ProPicks IA Filtros Explorador de dados Gráficos Guardado

X4 Pharmaceuticals Inc

NASDAQCM:XFOR

E.U.A. / Saúde / Biotecnologia

Resumo

Histórico Financeiro 10A

Preço Ação

0,26 USD


Key Metrics	Latest
Total Revenue	1,123 M
Adjusted EBITDA	-130,3 M
EBITDA Margin	-11.602,8%
Net Profit Margin	-8.411,3%
Total Assets	178,2 M
Total Debt	78,203 M

10Y Historical Financial Statements

Summary Financials


Summary Financials

	Fiscal Year Ending										Latest
(in millions)			Dec-16	Dec-17	Dec-18	Dec-19	Dec-20	Dec-21	Dec-22	Dec-23	12 Months

Revenue	0	0	0	0	0	0	3	0	0	0	1
% Growth		NA	NA	NA	NA	NA	NA	-100.0%	NA	NA

Adjusted EBITDA	0	0	(18)	(22)	(29)	(48)	(60)	(75)	(88)	(107)	(130)
% Margin	NA	NA	NA	NA	NA	NA	-1984.1%	NA	NA	NA	-11602.8%

Adjusted EBIT	0	0	(18)	(22)	(29)	(48)	(60)	(75)	(88)	(108)	(131)
% Margin	NA	NA	NA	NA	NA	NA	-1995.8%	NA	NA	NA	-11654.9%

Adjusted Net Income	0	0	(18)	(22)	(33)	(50)	(62)	(81)	(94)	(101)	(94)
% Margin	NA	NA	NA	NA	NA	NA	-2067.0%	NA	NA	NA	-8411.3%

Adjusted Basic EPS	NA	NA	(3.75)	(47.07)	(72.15)	(4.29)	(3.09)	(3.16)	(1.48)	(0.57)	(0.46)

Cálculos de Suporte

Income Statement

Balance Sheet

Statement of Cashflows


Income Statement
											Original
USD	Fiscal Year Ending										Latest
(in millions)			Dec-16	Dec-17	Dec-18	Dec-19	Dec-20	Dec-21	Dec-22	Dec-23	Sep-24
	FY - 9	FY - 8	FY - 7	FY - 6	FY - 5	FY - 4	FY - 3	FY - 2	FY - 1	FY	LTM

Revenue	0	0	0	0	0	0	3	0	0	0	1
% Growth	NA	NA	NA	NA	NA	NA	NA	-100.0%	NA	NA

Cost of Revenue	0	0	0	0	0	0	0	0	0	0	(0)
Gross Profit	0	0	0	0	0	0	3	0	0	0	1
% Revenue	NA	NA	NA	NA	NA	NA	100.0%	NA	NA	NA	55.9%

Research and Development	0	0	(13)	(17)	(20)	(30)	(42)	(51)	(61)	(72)	(75)
Selling and Marketing	0	0	0	0	0	0	0	0	0	0	0
General and Admin	0	0	(5)	(5)	(9)	(18)	(21)	(25)	(27)	(36)	(56)
Other Inc / (Exp)	0	0	0	1	(4)	(4)	0	(10)	(2)	8	117
Total Operating Exp	0	0	(18)	(22)	(33)	(52)	(63)	(85)	(90)	(100)	(15)

Operating Income	0	0	(18)	(22)	(33)	(52)	(60)	(85)	(90)	(100)	(14)
% Revenue	NA	NA	NA	NA	NA	NA	-1985.6%	NA	NA	NA	-1270.8%

Interest Expense	0	0	(0)	(0)	(0)	(1)	(2)	(4)	(4)	(1)	(2)
Pre-tax Income	0	0	(18)	(22)	(33)	(53)	(62)	(89)	(94)	(101)	(17)
Earnings of Discontinued Ops.	0	0	0	0	0	0	0	0	0	0	0
Provision for Taxes	0	0	0	0	0	0	(0)	(0)	(0)	(0)	(0)
Net Income to Company	0	0	(18)	(22)	(33)	(53)	(62)	(89)	(94)	(101)	(17)
% Margin	NA	NA	NA	NA	NA	NA	-2071.0%	NA	NA	NA	-1492.3%

Minority Interest in Earnings	0	0	0	0	0	0	0	0	0	0	0
Net Income to Stockholders	0	0	(18)	(22)	(33)	(53)	(62)	(89)	(94)	(101)	(17)

Preferred Dividends	0	0	(3)	(3)	(3)	(1)	0	0	0	0	0
Other Adj.	0	0	(0)	0	(0)	0	0	(14)	(3)	0	0

Net Income to Common	0	0	(21)	(25)	(36)	(53)	(62)	(103)	(96)	(101)	(17)
% Margin	NA	NA	NA	NA	NA	NA	-2071.0%	NA	NA	NA	-1492.3%

As Reported
Basic EPS (Continuing Ops)	0.00	0.00	(4.38)	(54.57)	(79.10)	(4.63)	(3.09)	(3.99)	(1.52)	(0.57)	(0.08)
Diluted EPS (Continuing Ops)	0.00	0.00	(4.38)	(54.57)	(79.10)	(4.63)	(3.09)	(3.99)	(1.52)	(0.57)	(0.08)

WA Basic Shares Out.	0.00	0.00	4.77	0.46	0.46	11.53	20.08	25.75	63.53	177.81	207.50
WA Diluted Shares Out.	0.00	0.00	4.77	0.46	0.46	11.53	20.08	25.75	63.53	177.81	207.67

EBITDA, EBIT Reconciliation
EBT, Incl. Unusual Items	0	0	(18)	(22)	(33)	(53)	(62)	(89)	(94)	(101)	(17)
Addback: Net Interest Expense	0	0	0	0	0	1	2	4	4	1	2
Addback: Other Non Operating Expenses, Total	0	0	(0)	(1)	3	(0)	(0)	(0)	2	(8)	(12)
Addback: Depreciation & Amortization	0	0	0	0	0	0	0	0	1	0	1
Addback: Restructuring Charges	0	0	0	0	0	0	0	0	0	0	0
Addback: Merger / Acquisition Expenses	0	0	0	0	0	0	0	0	0	0	0
Addback: Goodwill Impairment	0	0	0	0	0	0	0	10	0	0	0
Addback: Gain (Loss) On Sale Of Invest.	0	0	0	0	0	0	0	0	0	0	0
Addback: Gain (Loss) On Sale Of Assets	0	0	0	0	0	4	0	0	(1)	0	(105)
Addback: Asset Writedown	0	0	0	0	0	0	0	0	0	0	0
Addback: In Process R&D Expenses	0	0	0	0	0	0	0	0	0	0	0
Addback: Insurance Settlements	0	0	0	0	0	0	0	0	0	0	0
Addback: Legal Settlements	0	0	0	0	0	0	0	0	0	0	0
Addback: Other Unusual Items	0	0	0	1	0	1	0	0	0	0	0
Adjusted EBITDA	0	0	(18)	(22)	(29)	(48)	(60)	(75)	(88)	(107)	(130)
% Margin	NA	NA	NA	NA	NA	NA	-1984.1%	NA	NA	NA	-11602.8%

Adjusted EBIT	0	0	(18)	(22)	(29)	(48)	(60)	(75)	(88)	(108)	(131)
% Margin	NA	NA	NA	NA	NA	NA	-1995.8%	NA	NA	NA	-11654.9%

Adjusted Net Income Reconciliation
Net Income to Company	0	0	(18)	(22)	(33)	(53)	(62)	(89)	(94)	(101)	(17)
Addback: Unusual Items	0	0	0	1	0	4	0	10	(1)	0	(105)
Less: Tax Benefit of Unusual Items (26%)	0	0	0	(0)	(0)	(1)	(0)	(3)	0	0	27
Adjusted Net Income	0	0	(18)	(22)	(33)	(50)	(62)	(81)	(94)	(101)	(94)
% Margin	NA	NA	NA	NA	NA	NA	-2067.0%	NA	NA	NA	-8411.3%

Erro de carregamento

X4 Pharmaceuticals Inc

NASDAQCM:XFOR

E.U.A. / Saúde / Biotecnologia

Histórico Financeiro 10A